Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Elsbach

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|September 15, 1990
Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteinsC E Ooi, J Weiss, O Levy, et al.
The Journal of Biological Chemistry|October 21, 1994
Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytesJ Weiss, M Inada, P Elsbach, et al.
The Journal of Biological Chemistry|April 25, 1990
Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudateG W Wright, C E Ooi, J Weiss, et al.
The Journal of Clinical Investigation|March 13, 1999
Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteriaA K Foreman-Wykert, Y Weinrauch, P Elsbach, et al.
The Journal of Experimental Medicine|September 1, 1991
Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophilsC E Ooi, J Weiss, M E Doerfler, et al.
Biochimica Et Biophysica Acta|February 14, 1973
Some properties of phospholipases of alveolar macrophagesR Franson, S Beckerdite, P Wang, et al.
Infection and Immunity|January 1, 1994
Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coliC Capodici, S Chen, Z Sidorczyk, et al.
Immunology Today|February 1, 2000
Innate immunity: from plants to humansN Borregaard, P Elsbach, T Ganz, et al.
Infection and Immunity|February 1, 1977
Killing of Escherichia coli by a granulocyte fraction occurs without recognizable ultrastructural alterations in the bacterial envelope, as studied by freeze-fracture electron microscopyA J Van Houte, P Elsbach, A Verkleij, et al.
The Journal of Clinical Investigation|April 1, 1994
Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2M E Doerfler, J Weiss, J D Clark, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|September 15, 1990
Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteinsC E Ooi, J Weiss, O Levy, et al.
The Journal of Biological Chemistry|October 21, 1994
Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytesJ Weiss, M Inada, P Elsbach, et al.
The Journal of Biological Chemistry|April 25, 1990
Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudateG W Wright, C E Ooi, J Weiss, et al.
The Journal of Clinical Investigation|March 13, 1999
Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteriaA K Foreman-Wykert, Y Weinrauch, P Elsbach, et al.
The Journal of Experimental Medicine|September 1, 1991
Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophilsC E Ooi, J Weiss, M E Doerfler, et al.
Biochimica Et Biophysica Acta|February 14, 1973
Some properties of phospholipases of alveolar macrophagesR Franson, S Beckerdite, P Wang, et al.
Infection and Immunity|January 1, 1994
Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coliC Capodici, S Chen, Z Sidorczyk, et al.
Immunology Today|February 1, 2000
Innate immunity: from plants to humansN Borregaard, P Elsbach, T Ganz, et al.
Infection and Immunity|February 1, 1977
Killing of Escherichia coli by a granulocyte fraction occurs without recognizable ultrastructural alterations in the bacterial envelope, as studied by freeze-fracture electron microscopyA J Van Houte, P Elsbach, A Verkleij, et al.
The Journal of Clinical Investigation|April 1, 1994
Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2M E Doerfler, J Weiss, J D Clark, et al.
Pageof 11